Vascular Biogenics Profile

USD 0.2  2.58%

Vascular Biogenics Summary

Vascular Biogenics Ltd (VBLT) is traded on NASDAQ General Markets in USA. It is located in ISRAEL and employs 28 people. Vascular Biogenics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 230.37 M. Vascular Biogenics Ltd has 29.72 M outstanding shares of which 799.77 K shares are at this time shorted by private and institutional investors with about 2.25 trading days to cover. Vascular Biogenic currently holds about 28.16 M in cash with (17.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04.
Check Vascular Biogenics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Simplex Trading LlcCall Options12.01000
Knoll Capital Management LpCommon Shares860.6 K5.2 M
Macquarie Group LtdCommon Shares330 K2 M
View Vascular Biogenics Diagnostics

Selected Vascular Biogenics Ltd Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Vascular Biogenics Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 73% 
Equity ratings for Vascular Biogenics Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Vascular Biogenics Ltd., a clinicalstage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer and immuneinflammatory diseases in Israel. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameVascular Biogenics Ltd
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressOr Yehuda,
ExchangeNASDAQ General Markets
IndustryPharmaceutical Products
Contact Number972 3 634 6450
CurrencyUSD - US Dollar


Vascular Biogenics Analyst Recommendations
Target PriceAdvice# of Analysts
14.0Strong Buy3Odds
Vascular Biogenics Ltd current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Vascular Biogenics Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Vascular Biogenics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.14April 4, 2017
Vascular Biogenics Ltd normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate